title: Amine oxidase substrates mimic several of the insulin effects on adipocyte differentiation in 3T3 F442A cells.
abstract: We have previously reported that substrates of monoamine oxidase (MAO) and semicarbazide-sensitive amine oxidase (SSAO) exert short-term insulin-like effects in rat adipocytes, such as stimulation of glucose transport. In the present work, we studied whether these substrates could also mimic long-term actions of insulin. Adipose differentiation of 3T3 F442A cells, which is highly insulin-dependent, served as a model to test the effects of sustained administration of amine oxidase substrates. Daily treatment of confluent cells with 0.75 mM tyramine (a substrate of MAO and SSAO) or benzylamine (a substrate of SSAO) over 1 week caused the acquisition of typical adipocyte morphology. The stimulation of protein synthesis and triacylglycerol accumulation caused by tyramine or benzylamine reached one half of that promoted by insulin. This effect was insensitive to pargyline (an MAO inhibitor), but was inhibited by semicarbazide (an SSAO inhibitor) and by N-acetylcysteine (an antioxidant agent), suggesting the involvement of the H(2)O(2) generated during SSAO-dependent amine oxidation. Chronic administration of amine oxidase substrates also induced the emergence of adipose conversion markers, such as aP2, glycerol-3-phosphate dehydrogenase, the glucose transporter GLUT4, and SSAO itself. Moreover, cells treated with amines acquired the same insulin sensitivity regarding glucose transport as adipocytes classically differentiated with insulin. In all, most of the adipogenic effects of amines were additive to insulin. Our data reveal that amine oxidase substrates partially mimic the adipogenic effect of insulin in cultured preadipocytes. Furthermore, they suggest that SSAO not only represents a novel late marker of adipogenesis, but could also be directly involved in the triggering of terminal adipocyte differentiation.
authors.affiliation: Institut National de la Santé et de la Recherche Médicale, Unité 317, Institut Fédératif de Recherches 31, CHU Rangueil, 31403 Toulouse, France.
authors.forename: E
authors.initials: E
authors.lastname: Fontana
authors.forename: J
authors.initials: J
authors.lastname: Boucher
authors.forename: L
authors.initials: L
authors.lastname: Marti
authors.forename: J M
authors.initials: JM
authors.lastname: Lizcano
authors.forename: X
authors.initials: X
authors.lastname: Testar
authors.forename: A
authors.initials: A
authors.lastname: Zorzano
authors.forename: C
authors.initials: C
authors.lastname: Carpéné
mesh_terms: D016475:3T3 Cells; D000111:Acetylcysteine / Q000494:pharmacology; D017667:Adipocytes / Q000166:cytology / Q000187:drug effects*; D006631:Amine Oxidase (Copper-Containing) / Q000378:metabolism*; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D001596:Benzylamines / Q000378:metabolism / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects*; D005947:Glucose / Q000378:metabolism; D007328:Insulin / Q000494:pharmacology*; D051379:Mice; D018716:Molecular Mimicry; D013379:Substrate Specificity; D014439:Tyramine / Q000378:metabolism / Q000494:pharmacology*
chemical_list: D000975:Antioxidants; D001596:Benzylamines; D007328:Insulin; C030796:benzylamine; D006631:Amine Oxidase (Copper-Containing); D005947:Glucose; D000111:Acetylcysteine; D014439:Tyramine